Can Flagyl 500 mg Tablets Be Split to Give 250 mg TID?
No, you should not split Flagyl 500 mg tablets to achieve a 250 mg dose three times daily—instead, obtain 250 mg tablets or use the standard 500 mg three times daily dosing for most indications.
Why Splitting Is Not Recommended
The FDA drug label for Flagyl does not indicate that the 500 mg tablets are scored or designed to be split 1. Splitting unscored tablets leads to:
- Dose inaccuracy: You cannot reliably achieve exactly 250 mg per half-tablet
- Variable bioavailability: Uneven splitting may affect drug absorption
- Stability concerns: Exposed drug surfaces may degrade faster
- Patient safety risk: Inconsistent dosing undermines therapeutic efficacy
The Correct Approach Based on Indication
For C. difficile Infection (CDI)
The standard metronidazole dose is 500 mg orally three times daily for 10 days 2. This is the guideline-recommended regimen when metronidazole is used (though vancomycin or fidaxomicin are now preferred first-line agents) 3.
- Do NOT use 250 mg TID—this is subtherapeutic
- The 500 mg TID dosing is specifically validated in clinical trials 4
- Lower doses (250 mg) have only been studied in older trials with different dosing frequencies (250 mg four times daily) 4
For Other Infections
- Trichomoniasis: Either 2 g single dose OR 250 mg three times daily for 7 days 5—for the latter, use actual 250 mg tablets
- Bacterial vaginosis: 250 mg three times daily for 7 days 5—again, use 250 mg tablets
- Giardiasis and amebiasis: Various dosing regimens exist, but splitting is not recommended
Practical Solution
If you need 250 mg dosing:
- Order 250 mg metronidazole tablets (they are commercially available)
- Do not attempt to split 500 mg tablets
- If only 500 mg tablets are available and the indication truly requires 250 mg TID (like trichomoniasis or BV), consider alternative regimens or obtain the correct strength
If treating CDI or serious anaerobic infections:
- Use the full 500 mg three times daily as recommended 2, 3
- Do not underdose—metronidazole resistance and treatment failure are concerns
Important Caveats
- Neurotoxicity risk: Metronidazole carries risk of cumulative neurotoxicity with prolonged or repeated courses 2—avoid extended use
- Hepatic impairment: Dose reduction may be needed in severe liver disease 1
- Renal impairment: While single-dose pharmacokinetics are unchanged, metabolites accumulate in ESRD 1
The bottom line: Obtain the correct tablet strength rather than splitting. For most serious infections requiring metronidazole, 500 mg TID is the evidence-based dose.